PSP-001 is under clinical development by Prosit Sole Biotechnology (Beijing) and currently in Phase I for Norovirus Infections.

Inpegsomatropin is under clinical development by Xiamen Amoytop Biotech and currently in Phase II for Turner Syndrome.

Ganson NJ et al. (2006) Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene) glycol (PEG), in a phase I trial ...

Nanoparticles (NPs) are versatile tools in various applications, particularly in the biomedical fields. To understand their behavior within biological systems, it is crucial to measure their ...

After hours: January 3 at 7:01:55 PM EST Loading Chart for BMRN ...

Nanomedicine. 2012;7(8):1253-1271. Liposomes Liposomes are self-assembled artificial vesicles developed from amphiphilic phospholipids. These vesicles consist of a spherical bilayer structure ...

After hours: December 31 at 7:46:10 PM EST Loading Chart for RLYB ...

Despite recent therapeutic breakthroughs, cancer patients continue to face high recurrence and mortality rates due to treatment resistance. Cancer stem cells (CSCs), a subpopulation with self-renewal ...

The introduction of new agents immunomodulatory drugs (IMiDs) and proteasome inhibitors has brought a major shift in therapeutic paradigm in the treatment of newly diagnosed and refractory ...

After hours: 31 December at 17:34:22 GMT-5 ...